Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), Fellow (Gastroentrology and Hepatology)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), Fellow (Gastroentrology and Hepatology)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Gastroenterologist
M.B.B.S., M.D. (Gastroenterology), M.R.C.P (UK), ESEGH (UK)
Cardiologist
M.B.B.S, F.C.P.S
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
M.B.B.S, MRCP (UK)
Pediatric Gastroenterologist
M.B.B.S., F.C.P.S., F.C.P.S Gastroenterologist and Hepatologist and Nutritionist
Pediatric Gastroenterologist
M.B.B.S., F.C.P.S., F.C.P.S Gastroenterologist and Hepatologist and Nutritionist
Pulmonologist
M.B.B.S., F.C.P.S., Fellowship in Pulmonology, MRCP
Gastroenterologist
M.B.B.S., F.C.P.S. (Gastroenterology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures